Andahao, Eliana Kaye .
HRN: 23-24-82 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/25/2024
AMPICILLIN 500MG (VIAL)
02/25/2024
03/03/2024
IV
315mg
Q6
TC UTI
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes